Navigation Links
New Data Analyses on CONCERTA® Pediatric Treatment Include Insight on Handwriting Performance and Attention in ADHD
Date:10/29/2010

percent or more of patients in either sub-analysis presented today were consistent with those previously reported for CONCERTA® and included decreased appetite, upper abdominal pain, headache, irritability and initial insomnia. Two patients discontinued due to adverse events. No serious adverse events or deaths were reported.

About the CONCERTA® Clinical Trials The two posters presented today are secondary analyses taken from a data set comprised of two randomized, double-blind, placebo-controlled, crossover analog simulated-classroom trials examining the effects of CONCERTA® compared with placebo. The trials included a general population of children with ADHD and a wide range of endpoints based on standardized ADHD measurements, as well as observational input from subjects' parents, teachers and healthcare providers.  

About ADHDAttention Deficit Hyperactivity Disorder (ADHD) is a common and treatable medical condition characterized by inattention, hyperactivity and impulsivity that is estimated to affect about 5 million children(4) and 8 million adults(5) in the United States. While the exact cause of the condition is still unknown, scientists have focused their research on chemical messengers, or neurotransmitters, in the brain.(6)   Studies suggest that 76 percent of ADHD is linked to family genetics,(6) so the condition may be more common among people who have a close relative with ADHD.(7)

About CONCERTA®CONCERTA® is a prescription medication approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents and adults ages 6 to 65, as part of a total treatment program that may include counseling or other therapies.

IMPORTANT SAFETY INFORMATIONTalk to your healthcare professional for a proper diagnosis and treatment of ADHD.  Only a healthcare professional can decide whether medication is right for you or your child.

CONCERTA®
'/>"/>

SOURCE McNeil Pediatrics(TM)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
2. Reportlinker Adds The Top 10 Companies in the Hospital Pharmaceutical Market in China: Growth strategies, performance and SWOT analyses
3. The Top 10 Cardiovascular Device Companies: Market Trends, Growth Strategies, and SWOT Analyses Now Available at ReportsandReports
4. Shire Presents Results of Five Lialda(R) (mesalamine) Analyses at ACG 2009 Annual Scientific Meeting
5. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
6. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
7. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
8. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
9. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
10. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Research and Markets has announced the ... of Pharmaceutical Equipment Market in China, 2014-2018" report ... Trend Forecast of Pharmaceutical Equipment Market in ... pharmaceutical equipment industry in the aspects of ... business performance of domestic major enterprises, as well as ...
(Date:8/29/2014)... , Aug. 29, 2014  Unilife Corporation ("Unilife" ... announced today that it intends to release its financial ... ended June 30, 2014 after market trading ends on ... scheduled a conference call for 4:30 p.m. U.S. EDT ... at 6:30 a.m. AEST), to review the Company,s financial results, ...
(Date:8/29/2014)... 2014  Pacific Medical Data Solutions is excited to ... . The main website, along with the site,s blog, ... services and content relevant to the medical billing industry. ... viewers can now better understand how PMDS products help ... create a more visible platform about medical billing best ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2PMDS Announces New Website 2
... 2011 Mylan Inc. (Nasdaq: MYL ) ... Matrix Laboratories Limited) has received approval for three antiretroviral ... Health Organization,s (WHO) Prequalification of Medicines Programme. The products ... Tablet, 100 mg (heat-stable), and Tenofovir Disoproxil Fumarate and ...
... Medical imaging has revolutionized healthcare and is essential ... Modern equipment and protocols ensure that patients, physicians, and ... radiation, while still providing accurate results and diagnostic information. ... medical procedure must be balanced with the benefits of ...
Cached Medicine Technology:Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment 2Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment 3Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment 4AAPM Cautions that Patients Should Not Forgo Essential Medical Imaging 2
(Date:8/29/2014)... 2014 Carson Hearing Care has launched ... health care tips to local residents on a consistent ... offer weekly articles from the audiologists at Carson Hearing ... latest advances in hearing restoration research, new tinnitus treatment ... plan to write a new post on the blog ...
(Date:8/29/2014)... new report released yesterday by the Mental Health ... mental health training and education that police personnel ... prominent issue for Canada,s police community, and today,s ... law enforcement and people with mental illnesses," says ... with an interest in the area of police ...
(Date:8/29/2014)... team of scientists from the University of Colorado School ... process to expand production of stem cells used to ... extend beyond cancer, including treatments for inborn immunodeficiency and ... published Aug. 29 in PLOS ONE , ... Medicine and Stem Cell Biology and Taiga Biotechnologies, Inc. ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 LiveOps, Inc., ... service solutions, today announced that LiveOps has been selected ... Association's (MDA) Show of Strength Telethon for the third ... raises money and awareness to support MDA’s mission to ... aggressive and sometimes fatal muscle disease. This year’s program ...
(Date:8/29/2014)... Steven Reinberg ... News) -- The vast majority of American babies are ... serious illnesses, federal health officials said Thursday. More ... that prevent measles, mumps, and rubella (MMR); polio; hepatitis ... for Disease Control and Prevention. "Nationally, vaccination among ...
Breaking Medicine News(10 mins):Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 2Health News:Fort Worth Hearing Aid Leader, Carson Hearing Care, Creates Expert Blog to Discuss Important Hearing Healthcare Topics 3Health News:Report advocates improved police training 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3
... Liposuction and Body/Facial Reshaping visualizations TORONTO, May ... intelligent, life-like facial and body simulations performed ... of its latest plastic surgery visualization tool, ... LiftMagic.com, a popular online anti-aging visualization tool ...
... Development Authority, highlights New Jersey,s talented workforce and ... prosperityPARSIPPANY, N.J., May 13 Daiichi Sankyo, Inc. ... completed a major renovation and build-out of the ... facility to accommodate its growing workforce, creating sole ...
... announces that it has enrolled its 1,000th patient into ... R esponsiveness with A V erifyNow(R) Assay ... S afety). The trial is specifically designed to ... for patients who are poor responders to clopidogrel (Plavix(R)). ...
... Who: JEFFERSONS RESTAURANT VIP PREMIERE GALA, ... When: 5pm on Monday, May 18, 2009, ... Nashville,s historic Jefferson Street is known for its legendary live concerts with ... each contributing to the ambience of the rich R/B history of this ...
... High serum ferritin, being a hallmark of hereditary ... C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty ... has investigated the link between ferritin and steatosis ... southern European populations, high ferritin levels, after exclusion ...
... RWD(R) Healthcare Practice to Streamline Patient Flow and Improve ... some hospitals are struggling financially, St. Luke,s Episcopal Hospital ... efficient patient care with quality at its core. In ... is streamlining its transfer process for patients who need ...
Cached Medicine News:Health News:ModiFace Launches ReShapr.com, the World's First Free Online Plastic Surgery Visualization Tool 2Health News:Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters 2Health News:Daiichi Sankyo, Inc. Celebrates the Growth of Its U.S. Headquarters 3Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:Belmont University Graduate Launches Healthy Soul Food Restaurant on Nashville's Historic Jefferson Street 2Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 2Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 3Health News:St. Luke's Episcopal Hospital Announces Latest Phase of Efficiency, Excellence and Engagement Campaign 4
... standard trial frames. They are made of optical quality ... box. There are two sets available providing a full ... is that a patient can wear the prism with ... the patient to adapt to the use of the ...
... C Dermatome - reaching a new evolutionary plateau. ... to operate in the pulse mode, or to ... entire instrument and hose assembly is autoclavable and ... 2-, 3-, or 4-inch widths. Simply select the ...
A finely parallel striated (scratched) clear plastic membrane encapsulated between glass plates....
BD Visitec IOL Manipulator (Fenzl), blunt tip angled 45, 12.0 mm from end, fits 0.20 mm diameter holes and larger (3/bx, 1 bx/ca). For positioning intraocular lenses. Sure grip handles hand ridge ind...
Medicine Products: